|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61K 31/53 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3528817 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17804979.7 |
| Date of filing the European patent application | 2017-10-18 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057203 |
| Date | 2017-10-18 |
| (87) | Number | WO 2018/075650 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662409833 P | 2016-10-18 | US | |
| 201762516594 P | 2017-06-07 | US |
| (72) |
TAUB, Rebecca , US
|
| (73) |
Madrigal Pharmaceuticals, Inc. ,
200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428,
US
|
| (54) | METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST |
| METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST |